401Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study. (28th August 2018) - Todiere, G; Barison, A; Grigoratos, C; Cosentino, F; Negri, F; Angeramo, F; Novo, G; Falletta, C; Gentile, G; Nugara, C; Emdin, M; Re, F; et al.